Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
出版年份 2023 全文链接
标题
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
作者
关键词
-
出版物
AMERICAN JOURNAL OF OTOLARYNGOLOGY
Volume -, Issue -, Pages 104106
出版商
Elsevier BV
发表日期
2023-11-06
DOI
10.1016/j.amjoto.2023.104106
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care
- (2023) Cosimo Galletti et al. Pharmaceuticals
- Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
- (2022) Eugenio De Corso et al. Journal of Clinical Medicine
- Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis
- (2022) Michael E. Wechsler et al. Journal of Allergy and Clinical Immunology-In Practice
- Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment
- (2022) Eugenio De Corso et al. Journal of Clinical Medicine
- Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement
- (2022) Eugenio De Corso et al. Journal of Personalized Medicine
- Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP
- (2022) Elena Cantone et al. Journal of Personalized Medicine
- Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A “Real-Life” Observational Study in Naïve and Post-Surgical Patients
- (2022) Giancarlo Ottaviano et al. Journal of Personalized Medicine
- Dupilumab improves upper- and lower-airway disease control in chronic rhinosinusitis with nasal polyps and asthma
- (2021) Tanya M. Laidlaw et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Efficacy and Safety of treatment with biologicals for severe Chronic Rhinosinusitis with Nasal Polyps A systematic review for the EAACI Guidelines
- (2021) Ioana Agache et al. ALLERGY
- Efficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials
- (2021) Joaquim Mullol et al. ALLERGY
- Real‐life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps
- (2021) Rik Johannes Leonardus van der Lans et al. ALLERGY
- Olfactory Outcomes with Dupilumab in Chronic Rhinosinusitis with Nasal Polyps
- (2021) Joaquim Mullol et al. Journal of Allergy and Clinical Immunology-In Practice
- Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
- (2020) Jean Kim et al. Therapeutics and Clinical Risk Management
- Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps
- (2020) Sheridan M. Hoy DRUGS
- EUFOREA Consensus on Biologics for CRS w NP with or without asthma
- (2019) W J Fokkens et al. ALLERGY
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endotypes of chronic rhinosinusitis
- (2018) Jonathan Yip et al. Current Opinion in Otolaryngology & Head and Neck Surgery
- Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry
- (2016) Xinji Zhang et al. BMJ Open
- Phenotypes and Emerging Endotypes of Chronic Rhinosinusitis
- (2016) Claus Bachert et al. Journal of Allergy and Clinical Immunology-In Practice
- Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil
- (2013) Katsuhisa Ikeda et al. LARYNGOSCOPE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now